Vitamin D in viral associated lung cancers
维生素 D 在病毒相关肺癌中的作用
基本信息
- 批准号:10604870
- 负责人:
- 金额:$ 16.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-04-01 至 2023-03-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS related cancerAcquired Immunodeficiency SyndromeAdministrative SupplementAnimal Cancer ModelAnimal ModelAttenuatedBiological ModelsBlood group antibody DCancer EtiologyCancer PatientCause of DeathCessation of lifeDataDevelopmentDietary SupplementationDiseaseEtiologyGoalsHIVHIV InfectionsHighly Active Antiretroviral TherapyHuman PapillomavirusHuman papilloma virus infectionIncidenceInflammationInflammatoryInterleukin-17Kaposi SarcomaLeadLinkLiteratureMalignant NeoplasmsMalignant neoplasm of cervix uteriMalignant neoplasm of lungMalnutritionNon-Hodgkin&aposs LymphomaNutrientParentsPersonsPlayPopulationProductionPrognosisPublishingRoleTestingTherapeuticViralVitamin DVitamin D DeficiencyVitamin D supplementationVitamin DeficiencyWorkbasecytokinedietaryimprovedlung carcinogenesisnovelpreventtherapeutically effectivetumortumorigenic
项目摘要
SUMMARY
In recent years, the incidence of AIDS-defining cancers has dramatically decreased due to the highly active
antiretroviral therapy (HAART). In contrast, the incidence of the non-AIDS-defining cancers (NADC), especially
lung cancer (LC) has risen by more than 3 fold. In the U.S., LC has become the most common NADC with an
incidence rate of 204 cases per 100,000 person-years. LC is also the most common NADC cause of death and
accounts for 21% of cancer-related death in the human immunodeficiency virus (HIV)-infected population.
Thus, there is an unmet need to understand the underlying mechanism of this deadly disease and develop
more effective therapeutic strategy. Unlike other common HIV associated cancers such as cervical cancer,
non-Hodgkin's lymphoma, and Kaposi's sarcoma, HIV associated LCs do not have an established viral
etiology. Our parent R01 study (R01CA261258) shows that human papillomavirus (HPV) is causally associated
with LCs in the HIV(+) population, which adds conceptually to our understanding of HIV associated LCs and
provides potentially unique therapeutic opportunities. Based on strong preliminary evidence from both
published literatures and our new experimental data, we now hypothesize that Vitamin D (VitD) as an important
dietary nutrient plays a critical role in lung carcinogenesis in the HIV(+) population. In this administrative
supplement, we propose to investigate VitD's anti-tumorigenic role and therapeutic potential for HIV associated
LCs using our unique animal model system. We will examine an important concept of reversing the
HIV/HAART-induced VitD insufficiency/deficiency by dietary VitD supplementation can improve the prognosis
of HIV/HPV associated LCs. Successful completion of the supplement work can significantly enhance the
parent R01 study by further elucidating the underlying mechanism of this lethal disease and ultimately benefit
many HIV associated LC patients.
概括
近年来,由于艾滋病的高度活跃,导致艾滋病的癌症发病率急剧下降。
抗逆转录病毒治疗(HAART)。相比之下,非艾滋病定义癌症(NADC)的发病率,尤其是
肺癌 (LC) 增加了 3 倍多。在美国,LC 已成为最常见的 NADC
发病率为每10万人年204例。 LC 也是最常见的 NADC 死亡原因
占人类免疫缺陷病毒 (HIV) 感染人群中癌症相关死亡的 21%。
因此,了解这种致命疾病的潜在机制并开发新的药物的需求尚未得到满足。
更有效的治疗策略。与其他常见的与艾滋病毒相关的癌症(例如宫颈癌)不同,
非霍奇金淋巴瘤和卡波西肉瘤、HIV 相关 LC 没有确定的病毒性
病因学。我们的母版 R01 研究 (R01CA261258) 显示人乳头瘤病毒 (HPV) 与
与 HIV(+)人群中的 LC 相关,这从概念上增加了我们对 HIV 相关 LC 的理解
提供潜在独特的治疗机会。基于双方强有力的初步证据
根据已发表的文献和我们新的实验数据,我们现在假设维生素 D (VitD) 是一种重要的
膳食营养素在 HIV(+)人群的肺癌发生中起着至关重要的作用。在本行政
作为补充,我们建议研究 VitD 的抗肿瘤作用和 HIV 相关的治疗潜力
LC 使用我们独特的动物模型系统。我们将研究一个重要的概念:逆转
HIV/HAART 引起的 VitD 不足/缺乏通过饮食补充 VitD 可以改善预后
HIV/HPV 相关 LC 的数量。补充工作的顺利完成可以显着提高
母体R01研究通过进一步阐明这种致命疾病的潜在机制并最终受益
许多 HIV 相关的 LC 患者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Zhen Lin其他文献
Zhen Lin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Zhen Lin', 18)}}的其他基金
Human papillomavirus in HIV associated lung cancers
HIV相关肺癌中的人乳头瘤病毒
- 批准号:
10361530 - 财政年份:2021
- 资助金额:
$ 16.72万 - 项目类别:
Human papillomavirus in HIV associated lung cancers
HIV相关肺癌中的人乳头瘤病毒
- 批准号:
10577760 - 财政年份:2021
- 资助金额:
$ 16.72万 - 项目类别:
Human papillomavirus in HIV associated lung cancers
HIV相关肺癌中的人乳头瘤病毒
- 批准号:
10253590 - 财政年份:2021
- 资助金额:
$ 16.72万 - 项目类别:
Project 3-Human papillomavirus in HIV associated lung cancers
项目3-人类乳头瘤病毒在HIV相关肺癌中的作用
- 批准号:
10223350 - 财政年份:2020
- 资助金额:
$ 16.72万 - 项目类别:
Protecting Genetic Privacy through Risk Assessment
通过风险评估保护基因隐私
- 批准号:
7076320 - 财政年份:2006
- 资助金额:
$ 16.72万 - 项目类别:
Protecting Genetic Privacy through Risk Assessment
通过风险评估保护基因隐私
- 批准号:
7492263 - 财政年份:2006
- 资助金额:
$ 16.72万 - 项目类别:
Protecting Genetic Privacy through Risk Assessment
通过风险评估保护基因隐私
- 批准号:
7287366 - 财政年份:2006
- 资助金额:
$ 16.72万 - 项目类别:
Project 3-Human papillomavirus in HIV associated lung cancers
项目3-人类乳头瘤病毒在HIV相关肺癌中的作用
- 批准号:
9545029 - 财政年份:
- 资助金额:
$ 16.72万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 16.72万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 16.72万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 16.72万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 16.72万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 16.72万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 16.72万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 16.72万 - 项目类别: